were living with chronic hepatitis infections (HBV or HCV), globally in 2015. Moreover,
according to the similar source, in 2016, 10.4 million people fell ill with tuberculosis (TB), and
1.7 million died from the disease. Of this, 95% of TB deaths occurred in low and middle
income countries. According to the Antimicrobial Resistance (AMR) Review—an initiative of the
Wellcome Trust and the UK Department of Health—by 2050, drug-resistant tuberculosis could
kill around 2.5 million people per year. Therefore, these factors are expected to driver growth
of the market over the forecast period.
Browse Complete Report For More Information @
https://www.coherentmarketinsights.com/market-insight/sample-preparation-market-1594
Key players operating in the market include F. Hoffmann-La Roche AG, Bio-Rad Laboratories,
Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Danaher Corporation, Qiagen
N.V., PerkinElmer, Inc., Illumina, Inc. and Merck KgaA.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com